Personalis, Inc. (PSNL)
NASDAQ: PSNL · Real-Time Price · USD
9.50
+0.15 (1.60%)
Feb 3, 2026, 10:59 AM EST - Market open
Personalis Market Cap
Personalis has a market cap or net worth of $843.64 million as of February 3, 2026. Its market cap has increased by 148.51% in one year.
Market Cap
843.64M
Enterprise Value
721.68M
1-Year Change
148.51%
Ranking
Category
Stock Price
$9.50
Market Cap Chart
Since June 20, 2019, Personalis's market cap has decreased from $847.61M to $843.64M, a decrease of -0.47%. That is a compound annual growth rate of -0.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 830.32M | 17.46% |
| Dec 31, 2025 | 706.88M | 72.20% |
| Dec 31, 2024 | 410.49M | 298.67% |
| Dec 29, 2023 | 102.97M | 13.12% |
| Dec 30, 2022 | 91.02M | -85.76% |
| Dec 31, 2021 | 639.07M | -55.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GeneDx Holdings | 2.78B |
| Twist Bioscience | 2.52B |
| Neogen | 2.22B |
| NeoGenomics | 1.56B |
| Castle Biosciences | 1.15B |
| CareDx | 1.06B |
| OPKO Health | 967.30M |
| Fulgent Genetics | 809.90M |